For citations:
Shestakova M.V., Yudovich E.A. Once-weekly administration of dulaglutide, a glucagon-like peptide-1 receptor agonist, as monotherapy and combination therapy: review of the AWARD studies. Diabetes mellitus. 2017;20(3):220-230. (In Russ.) https://doi.org/10.14341/DM20151S1-112
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
